Treatment of CIDP
Authors:
- 15 September 2022
- journal article
- research article
- Published by BMJ in Practical Neurology
- Vol. 23 (1) , 46-53
Abstract
Chronic inflammatory demyelinating polyneuropathy is a disabling but treatable disorder. However, misdiagnosis is common, and it can be difficult to optimise its treatment. Various agents are used both for first and second line. First-line options are intravenous immunoglobulin, corticosteroids and plasma exchange. Second-line therapies may be introduced as steroid-sparing agents or as more potent escalation therapy. It is also important to consider symptomatic treatment of neuropathic pain and non-pharmacological interventions. We discuss the evidence for the various treatments and explain the practicalities of the different approaches. We also outline strategies for monitoring response and assessing the ongoing need for therapy.Keywords
This publication has 53 references indexed in Scilit:
- The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: A comprehensive review of the literatureJournal of Allergy and Clinical Immunology, 2012
- Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: A two-year studyJournal of the Neurological Sciences, 2011
- Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathiesNeurology, 2011
- Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevanceJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathiesJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Immunoadsorption inferior to plasma exchange in a patient with chronic inflammatory demyelinating polyradiculoneuropathyJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Plasma Exchange in Chronic Inflammatory Demyelinating PolyradiculoneuropathyNew England Journal of Medicine, 1986
- Combined azathioprine and prednisone in chronic inflammatory‐demyelinating polyneuropathyNeurology, 1985
- Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatmentAnnals of Neurology, 1982